Company / SG&A Expense
Co-Diagnostics, Inc. SG&A Expense History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$9.1M
FY2025
5-year range
$8.3M / $16.2M
FY2021-FY2025
Trend
-43.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has fluctuated over the past 9 years, ranging from $796,896 in FY2017 to $16M in FY2024.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of +21.0%.
Improved from $14M to $9M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -7.8%
- 5-Year CAGR
- +21.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +21.0%, indicating consistent growth.
- In FY2025, sg&a expense decreased 43.9% year-over-year.
- Peak sg&a expense was recorded in FY2024.
- Lowest sg&a expense in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.1M | -43.9% |
| FY2024 | $16.2M | +13.1% |
| FY2023 | $14.3M | +23.6% |
| FY2022 | $11.6M | +39.5% |
| FY2021 | $8.3M | +136.7% |
| FY2020 | $3.5M | -2.1% |
| FY2019 | $3.6M | +15.3% |
| FY2018 | $3.1M | +288.5% |
| FY2017 | $796.9K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026